Skip to content

EV / sales at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.7×-1.4×
Cardinal Health logo
Cardinal HealthCAH
0.2×0.0×
Viatris logo
ViatrisVTRS
1.9×+0.3×
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
3.1×-2.4×
Amcor logo
AmcorAMCR
1.5×-0.1×
Nordson logo
NordsonNDSN
6.2×+1.4×

Other financials

Income statement

See full
Revenue$844.9M+21.1%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$23.17B+11.6%
Enterprise value$22.97B+11.1%
P/E42.7×-1.7×
P/S7.2×0.0×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Calculated from West Pharmaceutical Services’s reported figures.

Based on the most recent quarter.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's EV / sales?
West Pharmaceutical Services (WST) reported EV / sales of 5.5× in Q1 2026.
How has West Pharmaceutical Services's EV / sales changed year-over-year?
West Pharmaceutical Services's EV / sales decreased by 0.2% year-over-year, from 5.6× to 5.5×.
What is the long-term trend for West Pharmaceutical Services's EV / sales?
Over 4 years (2021 to 2025), West Pharmaceutical Services's EV / sales has grown at a -14.2% compound annual growth rate (CAGR), from 43.1× to 23.3×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.